PCRX
Pacira BioSciences, Inc.
25.40$
+1.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +19.5% | +0.5% | +60.5% | +9.7% | +20.6% | +53.4% | +62.8% | -19.0% | -6.4% | -1.3% | -18.6% | |
| – | +17.9% | -3.8% | +60.9% | +22.2% | -14.5% | +59.5% | +32.9% | -42.5% | +2.3% | +46.1% | -26.5% | |
| – | +0.5% | -77.4% | +50.6% | +144.8% | -41.0% | +27.8% | +485.8% | -82.2% | +47.2% | +80.5% | -42.7% | |
| – | +0.5% | +8.6% | +80.4% | +23.2% | -23.9% | +78.7% | +25.8% | -56.0% | -3.5% | +74.0% | -50.8% | |
| – | +15.6% | +15.8% | +5.7% | +20.0% | +25.1% | +11.6% | +81.6% | +2.2% | +7.3% | +7.3% | +9.5% | |
| – | +110.7% | -49.3% | +32.4% | +17.3% | +20.0% | +10.9% | +52.4% | -2.5% | +8.6% | +20.1% | +22.0% | |
| – | +49.0% | +11.8% | +6.0% | +1.5% | -3.7% | +30.6% | +93.7% | -3.9% | – | – | – | |
| – | +30.0% | +51.4% | +18.1% | +12.4% | +60.5% | +0.0% | +45.8% | +12.4% | +0.0% | -100.0% | – | |
| – | -79.9% | +57,600.0% | +18.1% | – | – | -7.5% | +546.5% | -13.4% | -10.6% | -11.9% | -13.6% | |
| – | +10.5% | +0.7% | +102.3% | +5.5% | +29.3% | +37.5% | +105.4% | -32.6% | -22.3% | +10.1% | -26.2% | |
| – | +8.3% | -70.4% | +25.4% | +7.9% | +77.5% | +135.3% | +105.7% | -71.6% | -34.1% | +218.2% | -61.1% | |
| – | +0.6% | +4.5% | -99.7% | +4.3% | +1,360.1% | +3,082.8% | +143.6% | -88.8% | -59.2% | +1,107.8% | -95.3% | |
| – | +29.3% | -14.1% | +95.2% | -2.0% | -10.9% | -18.5% | +1.1% | +44.4% | +3.1% | +21.9% | -20.8% | |
| – | – | – | +154.0% | +5.2% | +5.3% | +2.3% | +115.5% | -2.8% | -21.7% | -25.4% | -3.0% | |
| – | +27.6% | +0.3% | +27.6% | +14.9% | +10.5% | +74.6% | +17.9% | +6.1% | +12.3% | -10.5% | -11.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +17.0% | -9.8% | +6.9% | +2.8% | +1.5% | +5.2% | +4.5% | +2.0% | +11.7% | -11.0% | -2.6% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.